Biology of acute leukaemia

Lancet

Volumn 349, Issue 9045, 1997, Pages 118-122

  Russell, N H ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; AGE; CANCER SURVIVAL; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; STEM CELL;

EID: 0031016298     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07185-1     Document Type: Review

References (20)

1. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukaemia: a study of 500 cases. Leukemia 1989; 3: 170-81.
2. Bennet J, Catovsky D, Daniel MT, et al. Proposals for classification of acute leukaemias. A report of the French-American-British co-operative group. Br J Haematol 1976; 33: 451-60.
3. Fialklow PJ, Jacobson R, Papayannopoulou T. Chronic myelocytic leukaemia. Clonal origin in a cell common to the granulocyte erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63: 125-31.
4. Van Lom K, Hagemeijer A, Vanderkerckhove F, Smit B, Lowenberg B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol 1996; 93: 594-600.
5. Keinanen M, Griffin JD, Bloomfield CD, Machniki J, de la Chapelle A. Clonal chromosome abnormalities showing multiple lineage involvement in acute myeloid leukaemia. N Engl J Med 1988; 318: 1153-58.
6. Fialklow P, Singer J, Raskind W, et al. Clonal development, stem cell differentiation and clinical remissions in acute nonlymphocytic leukaemia. N Engl J Med 1987; 317: 468-73.
7. Lapidot T, Siard C, Vormar J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-18.
8. Bonnet D, Dick JE. Purification of a cell initiating human leukaemia after transplantation into NOD-SCID mice. Br J Haematol 1996; 93 (suppl 2): 144.
9. Haase D, Feuring-Buske M, Konemann S, et al. Evidence for malignant transformation in acute myeloid leukaemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995; 86: 2906-12.
10. Turhan AG, Lemoire FM, Debert C, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukaemia. Blood 1995; 85: 2154-61.
11. Greaves MF. Stem cell origins of leukaemia and curability. Br J Cancer 1993; 67: 413-23.
12. McCulloch EA, Curtis JE, Messner MA, Senn JS, Germanson T. The contribution of blast cell properties to outcome variation in acute myeloblastic leukaemia. Blood 1982; 59: 601-08.
13. Dong F, Hoefsloot L, Schelen A, et al. Identification of a nonsense mutation in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994; 91: 4480-84.
14. Hunter AE, Rogers SY, Roberts IAG, Barrett A, Russell NH. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1994; 82: 899-903.
15. Watari K, Lansdorp PM, Dragowska W, Mayani H, Schrader J. Expression of interleukin-1βmRNA in candidate human hematopoietic stem cells. Blood 1994; 84: 36-13.
16. Secker-Walker L, Craig JM. Prognostic implications of break point and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukaemia: a review. Leukemia 1993; 7: 147-51.
17. Swansbury GJ, Lawler SD, Alimera G, et al. Long-term survival in acute myelogenous leukemia: A second follow-up of the 4th International Workshop on Chromosomes in Leukaemia. Cancer Gene Cytogenet 1994; 73: 1-18.
18. Willman CL. Immunophenotyping and cytogenetics in older adults with acute myeloid leukaemia: significance and expression of the multidrug resistance gene (MDR1). Leukemia 1996; 10 (suppl): 533-35.
19. Porwitt-McDonald, Janossy G, Overy K, et al. Leukemia associated changes identified by quantitative flow cytometry. IV CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood 1996; 87: 1162-69.
20. Del Poeta B, Stasi R, Aronica G, et al. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 1996; 87: 1992-2004.